Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Comphya is a Swiss medical device company specializing in the treatment of erectile dysfunction for patients who do not respond to oral therapy. Their innovative technology, CaverSTIM, is an implantable neurostimulator that selectively activates the nerve to trigger penile erection, providing a painless, safer, and more effective alternative to traditional treatments. The device allows for self-controlled stimulation via a wireless remote control, offering patients a comfortable and convenient solution. Comphya's focus is on bringing a better and more comfortable therapy for erectile dysfunction to those in need, with a recent successful inaugural surgery for spinal cord injury individuals marking a significant milestone in their clinical development program.
Friedhelm Christoph Hummel, Maximilian Jonas Wessel, Takuya Morishita, Traian Popa, Elena Beanato, Pierre Theopistos Vassiliadis, Fabienne Windel